Abstract
The effects of human recombinant IL-1β (BETALEUKIN) (6 × 104 – 6 × 106 U/Kg, intraperitoneally, single dose) on liver histology and cytochrome P450 (CYP450s)-mediated hepatic and renal monooxygenase activities were studied in adult male rats. rIL-1β (24 h after treatment) caused proinflammatory changes in liver histology in a dose-dependent manner which were the focal areas of hepatocellular dystrophy, perivascular polymorphonuclear cells infiltration, erythrocytes diapedesis, Kupffer cells and hepatocytes proliferation. Treatment with the rIL-1β caused the dose-dependent depression of the hepatic and renal CYP1A1/2-mediated ethoxyresorufin- O-deethylation (EROD), however showed variable effects of the CYP2E1-mediated p-nitrophenol hydroxylation (PNPH) and CYP3A-mediated erythromycin- N-demethylation (ERND). The hepatic PNPH activity was suppressed by the rIL-1β in doses of 6 × 106 U/kg and 6 × 104 U/Kg, and renal p-nitrophenol hydroxylation was suppressed only in a dose of 3 × 105 U/Kg. The hepatic ERND activity was up regulated after the rIL-1β treatment (3 × 105 U/Kg – 6 × 105), and the renal ERND activity was suppressed in a dose of 3 × 105 U/Kg. It is important that the possible effects of cytokines on individual CYP450s are characterized, so that concurrent drug therapy can be managed efficiently and pharmacokinetic interaction be avoided.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
